Don’t miss out on the next
OurCrowd provides accredited investors with unique pre-IPO investment opportunities, so you can get in early.
Today’s spotlight investment
Personalized Cancer Treatments
OncoHost can accurately predict patient response to cancer immunotherapies Read More
Time Left To Commit
- Days
- Hours
- Minutes
- Seconds
How it works
How can you invest in unique pre - IPO opportunities?
1. Get Access
Are you an accredited investor? Join our investor community and gain access to our exclusive VC-level deal-flow. It's free to join and to process your request.
Investments can be approved as quickly as 1 day.
2. Build Your Portfolio
Browse investment opportunities, review due diligence material, and identify pre-vetted opportunities that match your investment style.
Minimum investment is $10K.
3. Manage Investments
Invest and receive quarterly updates on your portfolio’s progress.
More unique investment opportunities will emerge as your portfolio matures.
Join free once, invest multiple times
Once accreditation is confirmed, you'll have access to new deals every month
We can't tell you everything...
By law, access to more sensitive and confidential investment details can only be given to accredited investors and are made available after sign up.
Eliminating barriers to startup investing since 2013
Venture capital is a great thing, if you're on the inside.
Public markets were built for IPOs, but in recent years tech companies have chosen to remain private longer, keeping significant growth opportunities in the private market, where the average investor does not have access. We're here to give individual, accredited investors access to these private investment opportunities, with the protection of our highly-selective, due diligence process.
Learn more from our founder
Companies are now delaying their IPO until much later in their lifecycle, and individual investors have been missing out on these significant growth opportunities.
OurCrowd has been featured in:
Top OurCrowd Powered Exits
OurCrowd curates once-in-a-lifetime startup investment opportunities. Find out about the next big thing before it's the next big thing.
In addition to single-company investments, OurCrowd offers two great options for you to better diversify your portfolio.
Funds
Diversified & Managed
Made for passive investors who are interested in distributing funds across a whole sector (e.g. Medical, Cybersecurity, Agriculture & Food, etc.)
Minimum investment - $50K
Portfolio Reserve
Diversified & Personalized
Made for active investors who prefer to seamlessly select a portfolio of investments on their own.
Minimum investment - $30K
Get personalized investment recommendations
Have you ever invested in startups before?
OurCrowd works just as well for first time investors or veteran angel investors. Experienced investors are usually approved faster, in as few as 24 hours.
This would be my first investment
Yes, I have a portfolio of 3+ companies
This would be my first investment
Copyright © 2020 OurCrowd. All rights reserved.
Featured Opportunity
Why are we investing in OncoHost?
OncoHost's technology determines whether cancer therapy works for specific patients. Read More
Multi-center clinical trials are underway with more than 650 patients. Read More
Misapplication of incorrect cancer treatments can cost $100,000 or more. Read More
World-first simple blood test helps match therapy to patient, offering better choices to fight cancer
OncoHost is an Israeli company that has developed a unique way to accurately predict patient response to cancer immunotherapies, helping oncologists to find strategies to overcome treatment resistance.
Precision medicine is often based on genetic information about the patient. Genetics, however, only tells part of the story. The interaction between the patient’s body (the “host”), the treatment, and the tumor is complex. OncoHost has created a tool to help understand this complex interaction.
Cancer treatment that is life-saving for some patients may harm others. Read More
More Opportunities
OurCrowd curates once-in-a-lifetime opportunities to invest in pre-IPO companies and funds
Cyabra is an Israeli Information Warfare company combating the spread of disinformation and fake news.
At OurCrowd, we are fortunate to be able to play an important role in supporting those on the front lines of COVID-19...
Solutions for experienced investors